The largest database of trusted experimental protocols

Cov2 2130

Manufactured by Regeneron Pharmaceuticals

COV2-2130 is a laboratory equipment product designed for research purposes. It serves as a tool for researchers to study and analyze various aspects related to the COVID-19 virus.

Automatically generated - may contain errors

3 protocols using cov2 2130

1

Monoclonal Antibody Production and Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The monoclonal antibodies tested in this study were constructed and produced at Columbia University, except for REGN10933, REGN10987, COV2-2196, and COV2-2130, which were provided by Regeneron Pharmaceuticals, Inc., and CB6, which was provided by Baoshan Zhang and Peter D. Kwong (10 (link)).
+ Open protocol
+ Expand
2

Antibody Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were expressed as previously described18 (link). Briefly, Vh and Vl genes for each antibody were codon optimized and synthesized (GenScript), and then inserted into mammalian expression vectors. These plasmids were transiently transfected into Expi293 cells (Thermo Fisher) using polyethylenimine and cultured for 5 days, and then the antibody was purified by affinity chromatography using rProtein A Sepharose (GE). REGN10933, REGN10987, COV2-2130 and COV2-2196 were provided by Regeneron Pharmaceuticals, Brii-196 and Brii-198 were provided by Brii Biosciences, and CB6 was provided by B. Zhang and P. Kwong (NIAID).
+ Open protocol
+ Expand
3

Antibody Expression and Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were expressed as previously described17 (link). Heavy chain variable and light chain variable genes for each antibody were synthesized (GenScript), then transfected into Expi293 cells (Thermo Fisher Scientific) and purified from the supernatant by affinity purification using rProtein A Sepharose (GE). REGN10987, REGN10933, COV2-2196 and COV2-2130 were provided by Regeneron Pharmaceuticals; Brii-196 and Brii-198 were provided by Brii Biosciences; CB6 was provided by B. Zhang and P. Kwong (National Institutes of Health (NIH)) and ZCB11 was provided by Z. Chen (University of Hong Kong).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!